Pancreaze FDA Approval History
FDA Approved: Yes (First approved April 12, 2010)
Brand name: Pancreaze
Generic name: pancrelipase
Dosage form: Delayed-Release Capsules
Company: Ortho-McNeil Pharmaceutical, LLC
Treatment for: Pancreatic Exocrine Dysfunction
Pancreaze (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
Development Timeline for Pancreaze
|Apr 13, 2010||ApprovalFDA Approves Pancreatic Enzyme Product, Pancreaze|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.